已收盤 10-03 16:00:00 美东时间
+0.050
+0.72%
Novo Nordisk (NVO), which is down ~36% year-to-date, is giving some employees a choice: Accept a demotion with lower pay or receive a pink slip. Some workers were given just 24 hours to proceed with a...
09-30 22:10
Ozempic® is now available at this reduced price to eligible self-pay LifeMD patientsNEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care, today
09-30 20:12
LifeMD has announced a collaboration with Novo Nordisk to offer Ozempic<sup>®</sup> (semaglutide) at $499 per month for eligible self-pay and uninsured patients, including those whose insurance doesn’t cover GLP-1 therapies. The telehealth platform integrates with NovoCare<sup>®</sup> Pharmacy, providing access to all FDA-approved dose strengths of Ozempic<sup>®</sup> and Wegovy<sup>®</sup>, along with virtual consultations, clinical support, dia...
09-30 12:00
LifeMD, Inc. 8.875% CUM PFD A (NASDAQ:LFMDP) declares $0.5547/share quarterly dividend. Forward yield 9.25% Payable Oct. 15; for shareholders of record Oct. 3; ex-div Oct. 3. See LFMDP Dividend Scorec...
09-24 04:11
LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the expansion of its state-of-the-art affiliated pharmacy to include advanced non-sterile compounding capabilities for oral
09-18 20:12
<p>LifeMD, Inc. announced the expansion of its affiliated pharmacy to include advanced non-sterile compounding capabilities for oral and topical medications. This enhancement supports specialized therapies, improves patient convenience, and increases operational efficiency. The pharmacy can now formulate customized medications, including allergen-free and combination products not commercially available. LifeMD’s strategic expansion aligns with it...
09-18 12:00
SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its ex...
09-10 06:24
NEW YORK, Sept. 1, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been ...
09-02 00:00
LifeMD (NASDAQ:LFMD) is up ~3% in Wednesday trading after KeyBanc Capital Markets issued a bullish note on the telehealth provider. The bank said that proprietary cardholder data for LifeMD and its Re...
08-21 01:52
诺和诺德公司周一表示,将向美国符合条件的 2 型糖尿病自费患者提供每月 499 美元的糖尿病药物 Ozempic。 本月早些时候,该公司曾表示,预计今年其重...
08-18 22:08